Vaccine Grade

IFAVax

  • Product Name
  • IFAVax - Incomplete Freund’s Adjuvant
  • Cat.No.
  • ADJU-013CL-1
  • Product Information and Content
  • IFAVax Incomplete Freund’s adjuvant (IFA) is a water-in-oil emulsion that does not contain Mycobacteria. 
    IFAVax is available in three quantities: 10 mL, 5x10 mL & 10x10 mL.
  • Storage and Stability
  • Store IFA at +4°C away from light. Do not freeze.
  • Description

  • Incomplete Freund’s Adjuvant (IFA) is a water-in-oil emulsion that is similar to the Complete Freund’s Adjuvant (CFA) without addition of heat-killed mycobacteria (Mycobacterum butyricum). IFA and CFA are among the most used adjuvants and have been used extensively in experimental immunology. IFA has been used for decades in practical veterinary vaccination.
    IFAVax consists of a mixture of mineral oil and emulsifier in a ratio of 85% v/v oil and 15% v/v emulsifier. Importantly, the IFAVax is not a pre-formed emulsion and thus it must be mixed with an equal volume of aqueous solution of antigen and subsequently emulsified prior to use. The emulsifier is mannide monooleate, an ester consisting of mannitol as the hydrophilic residue and oleic acid (unsaturated C18 fatty acid) as the hydrophobic part. Even if the mechanisms of action of oil emulsions are still poorly understood, some evidences suggest a partial requirement for NOD2. Moreover, these emulsions are prone to cause cellular damage upon injection and thus, endogenous signals released during necrotic cell death may also contribute to their adjuvant activity. As opposed to CFA that induces principally a Th1 response, IFA that lacks mycobacterial components, primes a Th2 response and is thus less inflammatory. The engagement of Th2 outcome is due in part to the depot effect allowing a gradual and continuous release of antigen at the site of injection and an efficient raise in antibody titer. Freund’s adjuvant is designed to provide continuous release of antigens necessary for stimulating strong persistent immune response.
    The use of CFA should be used responsibly and with care in order to avoid or minimize the adverse effects of excessive inflammation.
    For most applications, CFA is usually only necessary for the initial immunization, while IFA is the adjuvant of choice for subsequent immunizations.
  • Method/Protocol
  • Recommendations before starting: 
    The inoculum should be free of extraneous microbial contamination; filtration of the antigen before mixing with the adjuvant is recommended.
    Injections containing Freund's complete adjuvant should be given subcutaneously: it is recommended to divide the inoculum containing the adjuvant into fractions so that not more than 0.1 mL is injected per site in mice or rats and 0.25 mL per site for rabbits. If skin necrosis results while following these guidelines, future injections should be spaced farther apart.
    1. for CFA only: vortex the vial to re-suspend the mycobacterium.
    2. Prepare 1 mL of IFAVax adjuvant in a plastic 3 cc luerlock syringe
    3. Dilute the antigen mixture in saline buffer or phosphate buffer for a final immunogen concentration of 10-100 µg/100 µL (sufficient for immunizing mice, rats and rabbits).
    4. Prepare 1 mL of antigen in a plastic 3 cc luer-lock syringe
    5. Form an emulsion:
    a. Connect the two syringes using a double-ended locking connector
    b. Press syringe barrels back and forth, transferring contents from one syringe to the other. A white emulsion should form immediately
    c. Mix for 5 to 10 min: a stable emulsion is produced
    d. The resulting emulsion should appear white, be stable and should not disperse when dropped into water
    NOTE: for smaller volumes, a prolonged mixing can be performed by vigourously pipetting or vortexing. For larger volumes use a tissue homogenizer to form the emulsion.
    6. Separate the syringes and remove air before attaching the needle (21g for mice or rats; 19g for rabbits)
    7. Inject into the animal according to the table below; the volume depends on the site of injection.
    8. It is necessary to separate multiple injection sites by a distance sufficient to avoid coalescence of inflammatory
    lesions.
    NOTE: Preferential route of administration for Freund’s adjuvant should be subcutaneous as it is the less disruptive. Other routes can be used:intramuscular, intradermal or intraperitoneal.

    SC = SC = Subcutaneous, IM = Intramuscular, ID = intradermal, IP = intraperitoneal,
    IV = IV = intravenous, N.R. = not recommended, N.A. = not acceptable
    Table 1: Recommended volume of Freund’s Adjuvant/Antigen emulsion per route of injection for different animal species (Adapted from Hendriken CFM et Hau J., 2003, in handbook of laboratory animal science vol I).

Online Inquiry

Name
Phone *
E-mail Address *
Service & Products Interested *
Project Description
Verification Code * Please input "diagnostics" as verification code.
Inquiry Basket